Maxia Strategies specializes in supporting biotechs with regulatory affairs and project development expertise. We also support in registration and market access activities in the US, EU and Switzerland. We submit MAA act as a MAH, and support in distribution and licensing request in Switzerland.
Cooperation possibilities
Based in Europe, Maxia Strategies maintains a global perspective through its own affiliates and its extensive collaborative network. Maxia Strategies continuously monitors global regulatory trends to balance the diverse requirements and ensure successful registration and product launch.
- http://www.maxiastrategies.com
- +41 61 511 4560
- office@maxiastrategies.com
- Dr. Karl E. Burgin
